USHABEN PATEL: Open Payments
NPI 1962740886 · WHITING, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 10 payments from 5 companies in 2025. Trend: 2023 $261 · 2024 $189 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $49 |
| Dexcom, Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $17 |
Products named: VRAYLAR, Dexcom G6 Transmitter, EVKEEZA, AIRSUPRA, FARXIGA.
Industry payments across IN — which companies pay providers there.
